Crescent Biopharma Stock (NASDAQ:CBIO)
Previous Close
$12.27
52W Range
$10.83 - $63.00
50D Avg
$12.87
200D Avg
$20.02
Market Cap
$157.68M
Avg Vol (3M)
$114.78K
Beta
-
Div Yield
-
CBIO Company Profile
Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.